Diabetic Macular Oedema, Retina/Vitreous
The 0.19 mg Fluocinolone Acetonide Intravitreal Implant – A Review on its Use in Diabetic Macular Oedema from the Association for Research in Vision and Ophthalmology Annual Meeting 2018
Anat Loewenstein, Usha Chakravarthy, Francesco Bandello
European Ophthalmic Review. 2018;12(2):88–97 DOI: https://doi.org/10.17925/EOR.2018.12.2.88
Diabetic macular oedema (DMO) is a complication of diabetic retinopathy, a microvascular ocular complication of diabetes mellitus.1 The blood–retinal barrier (BRB) is a specialised structure, which tightly regulates, maintains and balances the levels of electrolytes, protein and fluid in the retinal tissues – a function that is central to the maintenance of normal visual acuity […]